Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex in Pain Due to Diabetic Neuropathy
NCT00710424Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in diabetic neuropathy, sponsored by Jazz Pharmaceuticals plc. Started Jul 2005; status: completed.
02
Drugs
cannabidiol
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00710424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710424.